Last reviewed · How we verify
Diphtheria-tetanus-acellular pertussis vaccine
Diphtheria-tetanus-acellular pertussis vaccine is a Biologic drug developed by CanSino Biologics Inc.. It is currently in Phase 1 development. Also known as: Boostrix vaccine.
At a glance
| Generic name | Diphtheria-tetanus-acellular pertussis vaccine |
|---|---|
| Also known as | Boostrix vaccine |
| Sponsor | CanSino Biologics Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diphtheria-tetanus-acellular pertussis vaccine CI brief — competitive landscape report
- Diphtheria-tetanus-acellular pertussis vaccine updates RSS · CI watch RSS
- CanSino Biologics Inc. portfolio CI
Frequently asked questions about Diphtheria-tetanus-acellular pertussis vaccine
What is Diphtheria-tetanus-acellular pertussis vaccine?
Diphtheria-tetanus-acellular pertussis vaccine is a Biologic drug developed by CanSino Biologics Inc..
Who makes Diphtheria-tetanus-acellular pertussis vaccine?
Diphtheria-tetanus-acellular pertussis vaccine is developed by CanSino Biologics Inc. (see full CanSino Biologics Inc. pipeline at /company/cansino-biologics-inc).
Is Diphtheria-tetanus-acellular pertussis vaccine also known as anything else?
Diphtheria-tetanus-acellular pertussis vaccine is also known as Boostrix vaccine.
What development phase is Diphtheria-tetanus-acellular pertussis vaccine in?
Diphtheria-tetanus-acellular pertussis vaccine is in Phase 1.
Related
- Manufacturer: CanSino Biologics Inc. — full pipeline
- Also known as: Boostrix vaccine
- Compare: Diphtheria-tetanus-acellular pertussis vaccine vs similar drugs
- Pricing: Diphtheria-tetanus-acellular pertussis vaccine cost, discount & access